← Eichor
Study identifier: NCT07465523 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Novel Approach in the Evaluation of Breast Masses With Doppler US

Condition: Breast Neoplasm Female · Benign Breast Neoplasm · Malign Breast Neoplasm  ·  Sponsor: Ahmet Yesildag

PhaseN/A
Planned participants90
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

In cases with breast masses, Doppler resistive index values will be calculated for the mass and surrounding healthy tissue and the opposite healthy breast tissue, and their effect on distinguishing between benign and malignant masses will be evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Ahmet Yeşildağ, Prof.Dr  ·  +905057728297  ·  ahmetysd@hotmail.com

Gökçe Merve Arman, Dr.  ·  +905058734762  ·  gmerveturgut@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Karamanoğlu Mehmetbey University, KEAHKaraman, Lütfen Seçiniz., Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07465523